Skip to content
PeptideAgent

Clinics in Kansas

By the PeptideAgent Editorial Team. Draft, pending editorial review.  Last verified

What Kansas law means for peptide clinics: who may prescribe, whether pharmacies may compound GLP-1 drugs (limited), how to check a clinic, and verified listings.

Kansas at a glance

503A framework
Follows the federal 503A framework
Telehealth prescribing
Regulatory: Telehealth allowed
Asynchronous prescribing
Regulatory: Async unclear
Compounded GLP-1 access
Regulatory: Compounded GLP-1 limited

Verified clinics serving Kansas

No verified clinics serving Kansas are listed yet. A provider appears here only after it passes the verification checklist, and those checks are still under way.

Looking for care now? Start with what the law allows where you live, then how a legitimate prescription works.

Run a pharmacy, clinic, or telehealth service? Apply for a listing.

Peptide access rules in Kansas

Yes. A Kansas resident can obtain FDA approved peptides such as semaglutide and tirzepatide by prescription from a Kansas-licensed provider, including by telemedicine under the Kansas Telemedicine Act (K.S.A. 40-2,210 through 40-2,216), which says telemedicine may be used to establish a valid provider-patient relationship and applies in-person standards of practice and prescribing law. Compounded peptides are available when eligible under federal 503A rules and dispensed by a Kansas pharmacy or a pharmacy registered as a nonresident pharmacy under K.S.A. 65-1657, which bars unregistered out-of-state pharmacies from shipping prescription drugs to Kansas patients or prescribers' offices. [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11]

Compounded GLP-1 access in Kansas

Kansas patients using telehealth GLP-1 programs should confirm the prescriber holds a Kansas license and that the dispensing pharmacy has a Kansas nonresident pharmacy registration under K.S.A. 65-1657. The Kansas Board of Pharmacy's statement on compounding and dispensing GLP-1 and GIP receptor agonists (last updated August 26, 2026) says semaglutide and tirzepatide are no longer in shortage, that no salt form of either may be used in a compounded drug, and that even when compounding is otherwise allowed, a non-pharmaceutical grade bulk substance or one not made in an FDA-registered establishment is prohibited. It also says pre-printed or check-box prescriptions may not document the patient-specific need that copies of approved drugs require, and that retatrutide and cagrilintide cannot be used to compound under federal law. [6] [10] [12] [13]

Research use only sellers in Kansas

K.S.A. 65-1657 bars unregistered nonresident pharmacies from shipping prescription drugs into Kansas and from advertising to Kansas residents. The Kansas Board of Pharmacy's GLP-1 statement adds that compounding pharmacies must use pharmaceutical-grade active ingredients, not research use, investigational, food, or supplement grade, with a certificate of analysis naming the original manufacturer, and that a pharmacist may not dispense a product compounded in a non-compliant manner. [6] [10] [14]

Kansas notes on specific peptides

  • Semaglutide: Available branded by prescription, including by telemedicine under the Kansas Telemedicine Act, which requires a report to your primary care physician within three business days when you consent. Compounded semaglutide is limited to documented patient-specific needs since the 503A grace period ended April 22, 2025. [8] [12]

How to check a clinic in Kansas

  1. Confirm the prescribing clinician's license with the Kansas medical or nursing board.
  2. Ask which pharmacy compounds or dispenses the peptide and check it in the Kansas State Board of Pharmacy license lookup. [1] [4] [5] [6] [10] [11]
  3. Confirm the peptide can be lawfully compounded: check its status on the regulatory tracker or its peptide page before paying.
  4. Walk away from any seller that labels a peptide "research use only" or "not for human consumption". See the research use only section above for what that means in Kansas. [6] [10] [14]

Common questions in Kansas

Will my regular doctor be told about a telehealth prescription in Kansas?

If you consent and have a primary care or treating physician, K.S.A. 40-2,212 requires the telemedicine provider to send that physician a report of the treatment within three business days. [8]

All peptide legal questions for Kansas

Sources

  1. [1]Kansas State Board of Pharmacy
  2. [2]Kansas State Board of Healing Arts
  3. [3]K.A.R. 100-77-3, Prescribing drugs by means of telemedicine (Kansas Secretary of State)
  4. [4]K.A.R. Article 68-13, State Board of Pharmacy regulations (68-13-2 definitions, 68-13-3 nonsterile, 68-13-4 sterile preparations)
  5. [5]Kansas Board of Pharmacy: Compounding compliance (House Bill 2068 adoption of USP 795, 797, and 825)
  6. [6]Kansas Board of Pharmacy: Statement on compounding and dispensing of compounded GLP-1 and GIP receptor agonists (updated August 26, 2026)
  7. [7]K.S.A. 40-2,211, Kansas Telemedicine Act definitions
  8. [8]K.S.A. 40-2,212, Telemedicine confidentiality, provider-patient relationship, and standards of practice
  9. [9]K.S.A. 40-2,214, Prescribing of drugs via telemedicine (rulemaking)
  10. [10]K.S.A. 65-1657, Nonresident pharmacy registration